<?xml version="1.0" ?>
<document id="62f01258c5feeb75f8e3e3d628f5094b4b20b8c8">
  <chunk id="62f01258c5feeb75f8e3e3d628f5094b4b20b8c8.c0" text="molecules In Vitro and in Vivo Studies of the Inhibitory Effects of Emodin Isolated from Polygonum cuspidatum on Coxsakievirus B 4">
    <entity charOffset="0-9" id="62f01258c5feeb75f8e3e3d628f5094b4b20b8c8.c0.e0" ontology_id="CHEBI_25367" text="molecules" type="chemical"/>
    <entity charOffset="68-74" id="62f01258c5feeb75f8e3e3d628f5094b4b20b8c8.c0.e1" ontology_id="CHEBI_42223" text="Emodin" type="chemical"/>
  </chunk>
  <chunk id="62f01258c5feeb75f8e3e3d628f5094b4b20b8c8.c1" text="The lack of effective therapeutics for Coxsackievirus B 4 (CVB 4 ) infection underscores the importance of finding novel antiviral compounds. Emodin (1,3,8-trihydroxy-6-methylanthraquinone) is one of the natural anthraquinone derivatives obtained from the root and rhizome of Polygonum cuspidatum. In the present study, the possibility of using emodin as a potential antiviral to treat CVB 4 infection was explored in vitro and in mice. Emodin reduced CVB 4 entry and replication on Hep-2 cells in a concentration-and time-dependent manner, with a 50% effective concentration (EC 50 ) of 12.06 Î¼M and selectivity index (SI) of 5.08, respectively. The inhibitory effect of emodin for CVB 4 entry and replication was further confirmed by a quantitative real time PCR (qPCR) assay. The results further showed that the mice orally treated with different dosages of emodin displayed a dose dependent increase of survival rate, body weight and prolonged mean time of death (MTD), accompanied by significantly decreased myocardial virus titers and pathologic scores/lesions. Moreover, emodin could inhibit CVB 4 -induced apoptosis in vitro and in vivo. Our results indicated that emodin could be used as potential antiviral in the post-exposure prophylaxis for CVB 4 infection.">
    <entity charOffset="121-130" id="62f01258c5feeb75f8e3e3d628f5094b4b20b8c8.c1.e0" ontology_id="CHEBI_22587" text="antiviral" type="chemical"/>
    <entity charOffset="142-148" id="62f01258c5feeb75f8e3e3d628f5094b4b20b8c8.c1.e1" ontology_id="CHEBI_42223" text="Emodin" type="chemical"/>
    <entity charOffset="212-225" id="62f01258c5feeb75f8e3e3d628f5094b4b20b8c8.c1.e2" ontology_id="CHEBI_22580" text="anthraquinone" type="chemical"/>
    <entity charOffset="345-351" id="62f01258c5feeb75f8e3e3d628f5094b4b20b8c8.c1.e3" ontology_id="CHEBI_42223" text="emodin" type="chemical"/>
    <entity charOffset="367-376" id="62f01258c5feeb75f8e3e3d628f5094b4b20b8c8.c1.e4" ontology_id="CHEBI_22587" text="antiviral" type="chemical"/>
    <entity charOffset="437-443" id="62f01258c5feeb75f8e3e3d628f5094b4b20b8c8.c1.e5" ontology_id="CHEBI_42223" text="Emodin" type="chemical"/>
    <entity charOffset="672-678" id="62f01258c5feeb75f8e3e3d628f5094b4b20b8c8.c1.e6" ontology_id="CHEBI_42223" text="emodin" type="chemical"/>
    <entity charOffset="861-867" id="62f01258c5feeb75f8e3e3d628f5094b4b20b8c8.c1.e7" ontology_id="CHEBI_42223" text="emodin" type="chemical"/>
    <entity charOffset="1078-1084" id="62f01258c5feeb75f8e3e3d628f5094b4b20b8c8.c1.e8" ontology_id="CHEBI_42223" text="emodin" type="chemical"/>
    <entity charOffset="1173-1179" id="62f01258c5feeb75f8e3e3d628f5094b4b20b8c8.c1.e9" ontology_id="CHEBI_42223" text="emodin" type="chemical"/>
    <entity charOffset="1207-1216" id="62f01258c5feeb75f8e3e3d628f5094b4b20b8c8.c1.e10" ontology_id="CHEBI_22587" text="antiviral" type="chemical"/>
  </chunk>
</document>
